People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital readmission, wound re-opening and hematoma after surgery, according to a large study led by investigators at Weill Cornell Medicine, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian.
GLP-1 drugs linked to fewer post-surgical complications in diabetic patients
- Post author:
- Post published:January 6, 2025
- Post category:uncategorized